Company Description
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States.
The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.
It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform.
It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies.
The company was founded in 2011 and is headquartered in Santa Monica, California.
Country | United States |
IPO Date | Sep 23, 2020 |
Industry | Health Information Services |
Sector | Healthcare |
Employees | 694 |
CEO | Scott W. Wagner |
Contact Details
Address: 2701 Olympic Boulevard Santa Monica, California 90404 United States | |
Phone | (855) 268-2822 |
Website | goodrx.com |
Stock Details
Ticker Symbol | GDRX |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $33.00 |
CIK Code | 0001809519 |
CUSIP Number | 38246G108 |
ISIN Number | US38246G1085 |
Employer ID | 47-5104396 |
SIC Code | 7374 |
Key Executives
Name | Position |
---|---|
Trevor Bezdek | Co-founder and Chairman |
Douglas Joseph Hirsch | Co-founder, Chief Mission Officer and Director |
Karsten Ian Voermann | Chief Financial Officer and Principal Financial Officer |
Romin Nabiey | Chief Accounting Officer and Principal Accounting Officer |
Scott W. Wagner | Interim Chief Executive Officer and Principal Operating Officer |
Mike Walsh | President and Executive Vice President of Prescription Marketplace |
Whitney Notaro | Vice President of Investor Relations |
Gracye Cheng | General Counsel and Secretary |
Andrew Slutsky | Chief Marketing Officer |
Vina M. Leite | Chief People Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 25, 2024 | ARS | Filing |
Apr 25, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Apr 25, 2024 | DEF 14A | Other definitive proxy statements |
Apr 5, 2024 | S-3 | Registration statement under Securities Act of 1933 |
Mar 14, 2024 | 8-K | Current Report |
Mar 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Mar 8, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Mar 7, 2024 | 8-K | Current Report |
Mar 7, 2024 | 8-K | Current Report |
Feb 29, 2024 | S-8 | Securities to be offered to employees in employee benefit plans |